An adverse reaction of skin hypersensitivity induced by lamotrigine —a case report
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: HUANG, Mei-Yueh (Show Chwan Memorial Hospital, Chang Hua, China Taiwan)
- Co-author(s): Chen, Latty Pei-Ying (Show Chwan Memorial Hospital, Chang Hua, China Taiwan)
Lamotrigine (LTG) is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is the first medication, since lithium, to be granted approval by the U.S. Food and Drug Administration (FDA) for maintenance treatment of bipolar type I. Furthermore, LTG is effective as an add-on agent either in monotherapy. LTG prescribing.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.